insiderwall
Menu
SuperinvestorInsider
Newron Pharmaceuticals SpA NP5

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Newron Pharmaceuticals SpA is a biopharmaceutical company headquartered in Bresso near Milan, Italy, specializing in the development of neuroscience-based treatments. Founded in 1999, the company focuses on advancing innovative therapies from discovery through to market, particularly in the central nervous system and n

SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryItaly
Employees22
TickerNP5

Statistics

Market Cap$306.7M
Revenue (TTM)$21.4M
Net Income
Net Margin
EPS
P/E11.41
P/S14.36
P/B
EV/EBITDA-58.49
ROE118.9%
Dividend Yield
Price$15.33

Data: Twelve Data · Revenue = mcap / P/S

Newron Pharmaceuticals SpA (NP5) — Azioni, fondamentali e superinvestor | InsiderWall